Registro:

Referencias:

• BESEDOVSKY, H.O., DEL REY, A., Immune-neuroendocrine circuits: Integrative role of cytokines (1992) Front. Neuroendocrinol, 13, pp. 61-94
• WICK, G., Immunoendocrine communication via the hypothalamo-pituitary-adrenal axis in autoimmune diseases (1993) Endocr. Rev, 14, pp. 539-563
• REFOJO, D., Integrating systemic information at the molecular level: Cross-talk between steroid receptors and cytokine signaling on different target cells (2003) Ann. N. Y. Acad. Sci, 992, pp. 196-204
• REFOJO, D., Transcription factor-mediated molecular mechanisms involved in the functional cross-talk between cytokines and glucocorticoids (2001) Immunol. Cell. Biol, 79, pp. 385-394
• RICCARDI, C., BRUSCOLI, S., MIGLIORATI, G., Molecular mechanisms of immunomodulatory activity of glucocorticoids (2002) Pharmacol. Res, 45, pp. 361-368
• AUPHAN, N., Immunosuppression by glucocorticoids: Inhibition of NF-kappa B activity through induction of I kappa B synthesis (1995) Science, 270, pp. 286-290
• SCHEINMAN, R.I., Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids (1995) Science, 270, pp. 283-286
• REICHARDT, H.M., Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor (2001) EMBO J, 20, pp. 7168-7173
• CALDENHOVEN, E., Negative cross-talk between RelA and the glucocorticoid receptor: A possible mechanism for the antiinflammatory action of glucocorticoids (1995) Mol. Endocrinol, 9, pp. 401-412
• DE BOSSCHER, K., VANDEN BERGHE, W., HAEGEMAN, G., The interplay between the glucocorticoid receptor and nuclear factor-kappaB or activator protein-1: Molecular mechanisms for gene repression (2003) Endocr. Rev, 24, pp. 488-522
• STOCKLIN, E., Functional interactions between Stat5 and the glucocorticoid receptor (1996) Nature, 383, pp. 726-728
• KOVALOVSKY, D., Molecular mechanisms and Th1/Th2 pathways in corticosteroid regulation of cytokine production (2000) J. Neuroimmunol, 109, pp. 23-29
• LIBERMAN, A.C., REFOJO, D., ARZT, E., Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation (2003) Arch. Immunol. Ther. Exp. (Warsz), 51, pp. 351-365
• MELCHIOR, F., SUMO-nonclassical ubiquitin (2000) Annu. Rev. Cell. Dev. Biol, 16, pp. 591-626
• JAMIESON, C.A., YAMAMOTO, K.R., Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 7319-7324
• ZACHARCHUK, C.M., Programmed T lymphocyte death. Cell activation- and steroid-induced pathways are mutually antagonistic (1990) J. Immunol, 145, pp. 4037-4045
• ASHWELL, J.D., LU, F.W., VACCHIO, M.S., Glucocorticoids in T cell development and function (2000) Annu. Rev. Immunol, 18, pp. 309-345
• MULLER IGAZ, L., CRE-mediated transcriptional activation is involved in cAMP protection of T-cell receptor-induced apoptosis but not in cAMP potentiation of glucocorticoid- mediated programmed cell death (2002) Biochim. Biophys. Acta, 1542, pp. 139-148
• PAEZ-PEREDA, M., Involvement of bone morphogenetic protein 4 (BMP-4) in pituitary prolactinoma pathogenesis through a Smad/estrogen receptor crosstalk (2003) Proc. Natl. Acad. Sci. USA, 100, pp. 1034-1039
• ABBAS, A.K., MURPHY, K.M., SHER, A., Functional diversity of helper T lymphocytes (1996) Nature, 383, pp. 787-793
• MOSMANN, T.R., COFFMAN, R.L., TH1 and TH2 cells: Different patterns of lymphokine secretion lead to different functional properties (1989) Annu. Rev. Immunol, 7, pp. 145-173
• ZHANG, D.H., Transcription factor GATA-3 is differentially expressed in murine Th1 and Th2 cells and controls Th2-specific expression of the interleukin-5 gene (1997) J. Biol. Chem, 272, pp. 21597-21603
• SZABO, S.J., A novel transcription factor, T-bet, directs Th1 lineage commitment (2000) Cell, 100, pp. 655-669
• ZHENG, W., FLAVELL, R.A., The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells (1997) Cell, 89, pp. 587-596
• FERBER, I.A., GATA-3 significantly downregulates IFN-gamma production from developing Th1 cells in addition to inducing IL-4 and IL-5 levels (1999) Clin. Immunol, 91, pp. 134-144
• OUYANG, W., Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism (1998) Immunity, 9, pp. 745-755
• MIYAURA, H., IWATA, M., Direct and indirect inhibition of Th1 development by progesterone and glucocorticoids (2002) J. Immunol, 168, pp. 1087-1094
• BLOTTA, M.H., DEKRUYFF, R.H., UMETSU, D.T., Corticosteroids inhibit IL-12 production in human monocytes and enhance their capacity to induce IL-4 synthesis in CD4+ lymphocytes (1997) J. Immunol, 158, pp. 5589-5595
• MORI, A., Two distinct pathways of interleukin-5 synthesis in allergen-specific human T-cell clones are suppressed by glucocorticoids (1997) Blood, 89, pp. 2891-2900
• HU, X., Inhibition of IFN-gamma signaling by glucocorticoids (2003) J. Immunol, 170, pp. 4833-4839
• JEE, Y.K., Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment (2005) J. Biol. Chem, 280, pp. 23243-23250
• FRANCHIMONT, D., Inhibition of Th1 immune response by glucocorticoids: Dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes (2000) J. Immunol, 164, pp. 1768-1774
• GILL, G., SUMO and ubiquitin in the nucleus: Different functions, similar mechanisms? (2004) Genes Dev, 18, pp. 2046-2059
• HAY, R.T., SUMO: A history of modification (2005) Mol. Cell, 18, pp. 1-12
• HERSHKO, A., The ubiquitin system for protein degradation and some of its roles in the control of the cell-division cycle (Nobel lecture) (2005) Angew Chem. Int. Ed. Engl, 44, pp. 5932-5943
• PICHLER, A., MELCHIOR, F., Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport (2002) Traffic, 3, pp. 381-387
• DESTERRO, J.M., RODRIGUEZ, M.S., HAY, R.T., SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation (1998) Mol. Cell, 2, pp. 233-239
• HAY, R.T., Control of NF-kappa B transcriptional activation by signal induced proteolysis of I kappa B alpha (1999) Philos. Trans. R. Soc. Lond. B Biol., Sci, 354, pp. 1601-1609
• CARBIA-NAGASHIMA, A., ARZT, E., Intracellular proteins and mechanisms involved in the control of gp130/JAK/STAT cytokine signaling (2004) IUBMB Life, 56, pp. 83-88
• KOTAJA, N., PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases (2002) Mol. Cell. Biol, 22, pp. 5222-5234
• JANG, H.D., PIAS3 suppresses NF-kappaB-mediated transcription by interacting with the p65/RelA subunit (2004) J. Biol. Chem, 279, pp. 24873-24880
• NISHIDA, T., YASUDA, H., PIAS1 and PIASxalpha function as SUMO-E3 ligases toward androgen receptor and repress androgen receptor-dependent transcription (2002) J. Biol. Chem, 277, pp. 41311-41317
• KOTAJA, N., ARIP3 (androgen receptor-interacting protein 3) and other PIAS (protein inhibitor of activated STAT) proteins differ in their ability to modulate steroid receptor-dependent transcriptional activation (2000) Mol. Endocrinol, 14, pp. 1986-2000
• LE DREAN, Y., Potentiation of glucocorticoid receptor transcriptional activity by sumoylation (2002) Endocrinology, 143, pp. 3482-3489
• POUKKA, H., Covalent modification of the androgen receptor by small ubiquitin-like modifier 1 (SUMO-1) (2000) Proc. Natl. Acad. Sci. USA, 97, pp. 14145-14150
• BOSSIS, G., Down-regulation of c-Fos/c-Jun AP-1 dimer activity by sumoylation (2005) Mol. Cell. Biol, 25, pp. 6964-6979
• GILL, G., Something about SUMO inhibits transcription (2005) Curr. Opin. Genet. Dev, 15, pp. 536-541
• KASIBHATLA, S., GENESTIER, L., GREEN, D.R., Regulation of fas-ligand expression during activation-induced cell death in T lymphocytes via nuclear factor kappaB (1999) J. Biol. Chem, 274, pp. 987-992
• DELIDOW, B.C., Inhibition of prolactin gene transcription by transforming growth factor-beta in GH3 cells (1991) Mol. Endocrinol, 5, pp. 1716-1722
• RAMSDELL, J.S., Transforming growth factor-alpha and -beta are potent and effective inhibitors of GH4 pituitary tumor cell proliferation (1991) Endocrinology, 128, pp. 1981-1190
• COFFEY, R.J., JR. et al. 1988. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol. Cell. Biol. 8: 3088-3093; CHEN, C.R., KANG, Y., MASSAGUE, J., Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program (2001) Proc. Natl. Acad. Sci. USA, 98, pp. 992-999
• MASSAGUE, J., BLAIN, S.W., LO, R.S., TGFbeta signaling in growth control, cancer, and heritable disorders (2000) Cell, 103, pp. 295-309
• KARSENTY, G., The genetic transformation of bone biology (1999) Genes Dev, 13, pp. 3037-3051

Citas:

---------- APA ----------

---------- CHICAGO ----------

---------- MLA ----------

---------- VANCOUVER ----------